Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation (Q80845729)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 2004
edit
Language Label Description Also known as
English
Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation
scientific article published on 01 November 2004

    Statements

    Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit